wwb

Windward Bio IPO: The Bull and Bear Case for WWB

Windward Bio Group AG (Nasdaq: WWB) is expected to list on 2026-11-13 at a price range of $16.00 to $18.00 per share. The biotech is betting that ultra-long-acting antibody drugs can win in asthma, COPD, and atopic dermatitis. The bull case is a large respiratory-immunology market and a cash-rich balance sheet; the bear case is that Windward has no approved products and still needs clinical execution to prove its lead programs.